Bristol-Myers Squibb spol. s r.o. secures contract for Antineoplastic agents - Medicinal preparations containing a fixed combination of the medicinal substances nivolumab and relatlimab - ATC L01FY02

Czechia, Jan. 14 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Antineoplastic agents - Medicinal preparations containing a fixed combination of the medicinal substances nivolumab and relatlimab - ATC L01FY02. The value of the contract is worth 8991637740 CZK.

Published by HT Digital Content Services with permission from Pivotal Sources....